In our monthly nutra regulatory round-up, we take a closer look at Hong Kong CBD ban, China’s plans in mass fortification of food staples, Singapore’s launch of food safety standards for online businesses and more.
2’-fucosyllactose (2’-FL) fermented using two types of genetically modified E. coli can now be used in infant formula for special medical purposes in Taiwan.
Breastfeeding mothers with a higher intake of vegetables, vitamins and metal elements produced more human milk oligosaccharides (HMOs) in their breast milk, according to an observational study funded by Abbott Nutrition R&D Center in Shanghai.
China’s food regulator is seeking public consultation on the use of the human milk oligosaccharide (HMO) 2’-fucosyllactose (2’-FL) in infant formula as well as in foods for toddlers and young children.
The human milk oligosaccharide (HMO) 2’-fucosyllactose (2’-FL) is generally the most abundant in colostrum, however, this is not the case for colostrum produced by mothers who are Malaysian Chinese, Japanese, and Samoans, said a review.
